[1] |
WAN Ping, LIU Liang, ZHANG Ping, ZHANG Zhongdong.
Influential factors of serum concentration/dosage ratio for schizophrenia patients after oral administration of olanzapine
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(9): 1024-1029.
|
[2] |
ZHOU Jianhua, LIU Kelan, WU Ganbin.
Effects of anti-platelet individual treatment guided by CYP2C19 polymorphism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(12): 1364-1367.
|
[3] |
TANG Xinyue, SHI Feng, LI Cuilin, LIU Jianqiu, LI Zhi.
Research progress of TERT promoter mutation in thyroid cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(3): 350-354.
|
[4] |
HUANG Hao, LI Xiu, XIAO Hong, FU Lei, YU Nan-cai, LIN Shi-he, YI Yan-dong.
siRNA targetgene c-myc downregulates human telomerase reverse tran-scriptase gene and telomere lengths in human colon cancer Colo320 cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(10): 1134-1138.
|
[5] |
ZHANG Ping-hu, ZHANG Juan, GAO Yi-xiang, ZHONG Min, SHANG Jing, ZHANG Lu-yong.
Finding and analysis of CYP3A4 new genotype from Chinese Han pop-ulation in East China
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(10): 1154-1157.
|
[6] |
HUANG Hao, YU Nan-cai, LIU Qian, YI Yan-dong, MA Wei.
Effects of water extract of purslane herb on protecting telomere length of senile mouse
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(7): 804-807.
|
[7] |
YI Juan, XIE Hai-tang, ZHOU Hong-hao.
Distribution of UGT1A9 C-2152T and UGT2B7 G211T mutants in Chinese Han population
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(4): 460-464.
|
[8] |
BAI Xiang-rong, JIANG De-chun, WANG Yu-qin, QI Xiao-lian.
Effects of CYP2C19 and CYP2C9 genotype on valproate clearance in patients with epilepsy in China
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(12): 1405-1410.
|
[9] |
ZHANG Hong-He, SHAO Ting-Jun, YANG Zhong-Guo.
Research on relation between genotype and effect of lamivudine in patient with hepatitis B virus infection
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(9): 1050-1053.
|
[10] |
LIU Jia-Jun, WU Xin-Yao, CAI GUI-Qing, WU Xiang-Lin, TONG Da-Yue, CHEN Li-Xian, PAN Xiang-Lin1, CHEN Chun-Yan1.
Anti-proliferation effect of interferon-αon Raji cells and its mechanism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(3): 270-274.
|
[11] |
FULIang-Qing, HUANG Feng, WU De-Zheng, GUO Jun-Hua.
Comparison of genotypePolymorphism of cytochrome CYP2C19 between Chinese Han subjects and Chinese Meng subjects
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003, 8(5): 551-553.
|
[12] |
NIEli-Gong,PAN Zhong-Bao, XU Song, lIU Xin-Min, CHEN Mao-Sen.
Effects of extracts of semen coicis on telomerase of squamouslung cancer cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003, 8(4): 419-421.
|
[13] |
YAN Feng-Xiang, LIAO Duan-Fang, CHOU Wen-Hwei, WEDLUND Peter-J, ROBBINS-WEILERT Dor-ris-K, RYDER Thomas-B, LIU Wei-Wei, PERBOST Clotilde, FAIRCHILD Maureen, KOCH Walter-H.
Comparison of CYP2D6 genotyping by allele-specific PCR with DXT phe-notype and gene chip testing1
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2002, 7(2): 100-105.
|
[14] |
JI Zhao-Ning, LIU Guo-Qing.
Telomerase and telomerase inhibitors
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2001, 6(4): 371-376.
|
[15] |
WU Xiang-Hua, YE Kai-He, HU Ai-Qun.
Ef fect of the all trans retinoic acid and Ara-con the telomerase activity of HL-60 cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2000, 5(1): 47-48.
|